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Epilepsy-associated Kv1.1 voltage-gated potassium channel subunits encoded by the 
Kcna1 gene have traditionally been considered absent in heart, but recent studies re-
veal they are expressed in cardiomyocytes where they could regulate intrinsic cardiac 
electrophysiology. Although Kv1.1 now has a demonstrated functional role in atria, 
its role in the ventricles has never been investigated. In this work, electrophysiologi-
cal, histological, and gene expression approaches were used to explore the conse-
quences of Kv1.1 deficiency in the ventricles of Kcna1 knockout (KO) mice at the 
organ, cellular, and molecular levels to determine whether the absence of Kv1.1 leads 
to ventricular dysfunction that increases the risk of premature or sudden death. When 
subjected to intracardiac pacing, KO mice showed normal baseline susceptibility to 
inducible ventricular arrhythmias (VA) but resistance to VA under conditions of sym-
pathetic challenge with isoproterenol. Echocardiography revealed cardiac contractile 
dysfunction manifesting as decreased ejection fraction and fractional shortening. In 
whole-cell patch-clamp recordings, KO ventricular cardiomyocytes exhibited action 
potential prolongation indicative of impaired repolarization. Imaging, histological, 
and transcript analyses showed no evidence of structural or channel gene expres-
sion remodeling, suggesting that the observed deficits are likely electrogenic due to 
Kv1.1 deficiency. Immunoblots of patient heart samples detected the presence of 
Kv1.1 at relatively high levels, implying that Kv1.1 contributes to human cardiac 
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1 |  INTRODUCTION
Potassium ion channels are a numerous and diverse set of mem-
brane proteins in the heart that are critical for mediating the 
repolarization of cardiac action potentials. Inherited or acquired 
potassium channelopathies can impair cardiac repolarization 
leading to common arrhythmias such as atrial fibrillation and 
long QT syndrome, which can increase the risk of mortality 
(Grant, 2009; Heijman et al., 2014; Nakano & Shimizu, 2016; 
Wilde & Bezzina, 2005). Nearly one-third of sudden unex-
plained death cases in children are associated with variants in 
genes encoding cardiac ion channels, especially those that con-
trol cardiac repolarization (Campuzano et al., 2014). Voltage-
gated Kv1.1 potassium channel α-subunits, which are associated 
with sudden unexpected death in epilepsy (SUDEP) in mice, 
have recently come to light as important regulators of cardiac 
repolarization and arrhythmia susceptibility in atria (Glasscock 
et al., 2015; Si et al., 2019). Following the discovery of Kv1.1 
expression in mouse cardiomyocytes, electrophysiology studies 
in mice demonstrated that the lack of Kv1.1 channel subunits 
impairs repolarization leading to prolonged atrial action poten-
tials and significantly increased risk of inducible atrial fibrilla-
tion (Glasscock et al., 2015; Si et al., 2019). Subsequent patient 
studies showed that human atrial cells also express Kv1.1 sub-
units and their associated currents, which are both augmented 
in chronic atrial fibrillation, suggesting a potential contribution 
by Kv1.1 channel remodeling (Glasscock et al., 2015). Previous 
studies of cardiac Kv1.1 have primarily focused on the atria, but 
Kv1.1 transcripts and protein are also detectable at low levels in 
mouse ventricular cardiomyocytes where their potential func-
tional contribution remains unknown (Glasscock et al., 2015).
Kv1.1 subunits are best known for their roles in the nervous 
system where their dysfunction or absence leads to neuronal 
hyperexcitability and neurological disease (Glasscock, 2019; 
Paulhus et al., 2020). Kv1.1 exhibits broad expression in the 
brain with predominant localization in axons where they con-
trol action potential morphology and firing properties (Jan & 
Jan, 2012; Wang et al., 1994). In humans, KCNA1 mutations 
cause the movement disorder episodic ataxia type 1 (EA1), 
as well as epilepsy, which is characterized by spontaneous 
recurrent seizures (Paulhus et al., 2020). Mice lacking Kv1.1 
due to global Kcna1 gene knockout (KO; i.e., Kcna1–/–) ex-
hibit spontaneous seizures with cardiorespiratory dysfunction, 
brain-driven autonomic cardiac abnormalities, and premature 
seizure-related death, making them a frequently used model 
for exploring neuro-cardio-respiratory mechanisms associ-
ated with SUDEP risk (Dhaibar et al., 2019; Glasscock et al., 
2010; Hutson et al., 2020; Iyer et al., 2020; Moore et al., 2014; 
Simeone et al., 2018). Mice with neuron-specific conditional 
knockout (cKO) of Kcna1 exhibit an ameliorated prema-
ture death phenotype, living significantly longer than global 
knockouts (Trosclair et al., 2020). Thus, although Kv1.1 de-
ficiency in neurons alone is sufficient for premature mortality, 
the preservation of cardiac Kv1.1 channels in cKO mice may 
provide an intrinsic cardioprotective role reducing the risk of 
seizure-related death.
In this work, electrophysiological, histological, and gene 
expression approaches were used to explore the role of ven-
tricular Kv1.1 channels at the organ, cellular, and molecular 
levels for the first time. Specifically, this study examined the 
hypothesis that Kv1.1 channels are functionally expressed in 
the ventricles where their absence leads to ventricular dys-
function that increases the risk of premature death. To test the 
consequences of Kv1.1 deficiency, in vivo intracardiac pac-
ing and echocardiography were performed in global Kcna1 
KO mice to measure ventricular arrhythmia susceptibility and 
myocardial contractility. Whole-cell patch-clamp recordings 
were then performed on isolated mouse ventricular cardio-
myocytes to examine the effects of genetic and pharmaco-
logical Kv1.1 ablation. Finally, Masson's trichrome histology 
and quantitative polymerase chain reaction (qPCR) analyses 
were used to evaluate the presence of deleterious structural 
and channel expression remodeling in Kv1.1-deficient ven-
tricles. Our findings reveal alterations in ventricular arrhyth-
mia susceptibility, contractility, and repolarization associated 
with the absence of Kv1.1, providing the first evidence that 
Kv1.1 is required for normal ventricular function.
2 |  MATERIALS AND METHODS
2.1 | Animals and Genotyping
Kcna1−/− knockout (KO) mice and wild-type (WT) siblings 
were used for experiments. KO mice carry null alleles of 
the Kcna1 gene (chromosome 6) resulting from the targeted 
deletion of the open reading frame, as previously described 
(Smart et al., 1998). The mice were bred and maintained 
electrophysiology. Taken together, this work describes an important functional role 
for Kv1.1 in ventricles where its absence causes repolarization and contractility defi-
cits but reduced susceptibility to arrhythmia under conditions of sympathetic drive.
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on a Black Swiss (Tac:N:NIHS-BC) genetic background. 
Animals were housed at 22°C, fed ad libitum, and maintained 
on a 12:12-h light-dark cycle. All procedures were performed 
in accordance with the guidelines of the National Institutes 
of Health (NIH), as approved by the Institutional Animal 
Care and Use Committee of the Louisiana State University 
Health Shreveport. For genotyping, genomic DNA was iso-
lated by the enzymatic digestion of tail clips using Direct-
PCR Lysis Reagent (Viagen Biotech, Los Angeles, CA). 
The genotypes of Kcna1 mice were determined by perform-
ing the PCR amplification of genomic DNA using allele-
specific primers: a KO-specific primer (5'-CCTTCTATC 
GCCTTCTTGACG-3'), a WT-specific primer (5'-GCCTCTG 
ACAGTGACCTCAGC-3'), and a common primer (5'-GCT 
TCAGGTTCGCCACTCCCC-3'). The PCR yielded ampli-
cons of ~337 bp for the WT allele and ~475 bp for the KO 
allele.
2.2 | Electrocardiography (ECG) and 
intracardiac electrophysiology
In vivo pacing studies were performed using age- and sex-
matched 4-month-old KO and WT mice of both sexes (for 
WT: n = 29, including 9 males, 20 females; for KO: n = 20, 
including 7 males, 13 females). Mice were anesthetized with 
isoflurane (2% for induction and 1.5% for maintenance of an-
esthesia; Apollo Tech 3 Vaporizer; Norvap) and placed in a 
supine position with limbs taped onto surface electrocardio-
gram (ECG) electrodes of a temperature-controlled procedure 
platform (Rodent Surgical Monitor, Indus Instruments, USA) 
which maintained core body temperatures at 37.0 ± 0.5°C. 
A Millar 1.1F octapolar EP catheter (EPR-800; Millar 
Instruments) was inserted via an incision in the internal right 
jugular vein. The catheter was advanced to the right atrium 
and ventricle using electrogram guidance and pacing cap-
ture to verify intracardiac position. A computer-based data 
acquisition system (PowerLab 16/30; ADI Instruments) was 
used to record a 4-lead body surface ECG and up to six in-
tracardiac bipolar electrograms (LabChart Pro software, ver-
sion 7; AD Instruments). To induce ventricular arrhythmias, 
programmed electrical stimulation (PES) was performed 
using 2-ms current pulses at 400 µA delivered by an external 
stimulator (STG-3008 FA; Multi Channel Systems). As done 
previously (Berul et al., 2001), a burst pacing protocol with 
eight 50-msec and four 30-ms cycle length train episodes 
was used. This sequence was repeated twenty times every 
3 s for a total of 70.4 s of the stimulation time. Ventricular 
arrhythmia (VA) was defined as a sequence of rapid sponta-
neous ventricular depolarizations that lasted >500 ms in re-
sponse to PES. Each animal underwent three PES trials and 
was considered to be VA-positive if VA was detected during 
any of the three trials. Following initial baseline PES trials, 
the β-adrenergic receptor agonist isoproterenol hydrochlo-
ride (ISO; Sigma-Aldrich, St. Louis, MO) was administered 
by intraperitoneal injection (4 mg/kg) to heighten ventricu-
lar susceptibility to arrhythmias, as done in human studies 
(Meester et al., 1997), and PES protocols were repeated. All 
VAs observed in the study were self-terminating. All meas-
urements were obtained by an observer blinded to genotype.
2.3 | Echocardiography
Echocardiograms were obtained from isoflurane-anesthe-
tized female KO and WT mice approximately 6–8 months of 
age (n = 9–13 per genotype) using a VisualSonics Vevo 3100 
Imaging System with a 30-MHz transducer to assess cardiac 
functional parameters as described previously (Abdullah 
et al., 2018, 2019; Alam et al., 2018). Only female mice were 
analyzed for echocardiography because no age-matched KO 
males were available at the time. Two-dimensional directed 
M-mode transthoracic echocardiographic images of the par-
asternal short axis were recorded to measure and compare 
the following parameters between genotypes: left ventricu-
lar internal diameter during systole (LVIDs); left ventricular 
internal diameter during diastole (LVIDd); left ventricular 
anterior and poster wall thickness during systole (LVAWs 
and LVPWs, respectively); and left ventricular anterior and 
poster wall thickness during diastole (LVAWd and LVPWd, 
respectively). These parameters were then used by an ob-
server blinded to genotype to calculate stroke volume, car-
diac output, ejection fraction fractional shortening, LV mass, 
and corrected LV mass using standard formulas (Gao et al., 
2011).
2.4 | Isolation of mouse ventricular myocytes
Ventricular myocytes were enzymatically isolated from 
hearts of age-matched male and female KO and WT mice 
(ages 6–8 weeks). Briefly, mice were intraperitoneally in-
jected with 5000 U/kg heparin (Sigma-Aldrich, St. Louis, 
MO) and euthanized by cervical dislocation. The heart was 
quickly removed and mounted on a Langendorff appara-
tus followed by 3-min retrograde perfusion with oxygen-
ated (100% O2) Ca
2+-free Tyrode's solution containing (in 
mmol/l): 140 NaCl, 5.4 KCl, 0.5 MgCl2, 10 glucose, and 
10 HEPES (pH 7.4; 37°C). Hearts were then perfused with 
the same Tyrode's solution but containing Liberase TH en-
zymes (0.025  mg/ml; Sigma-Aldrich) and bovine serum 
albumin (BSA; 1 mg/ml; Sigma-Aldrich). Left ventricular 
tissue was then removed and minced, and ventricular myo-
cytes were dispersed in KB solution containing (in mmol/l): 
80 KOH, 40 KCl, 25 KH2PO4, 3 MgSO4, 50 glutamic acid, 
20 taurine, 1 EGTA, 10 glucose, and 10 HEPES (pH 7.2 
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with KOH; 20–22°C). Cells were stored at room tempera-
ture (20–22°C) for at least 1 h before use. All chemicals 
used to make the solutions for cell isolations were obtained 
from Sigma-Aldrich.
2.5 | Whole-cell patch-clamp recordings
Whole-cell patch-clamp recordings were obtained from 
the isolated ventricular myocytes at 37°C. Borosilicate 
glass pipette (Warner Instruments, Hamden, CT) micro-
electrodes were used with tip resistances of 2–4 MΩ when 
filled with pipette solution. Electrodes were connected to 
a MultiClamp 700B microelectrode amplifier equipped 
with a CV-7B head stage (Axon Instruments, Molecular 
Devices, San Jose, CA). Electrical signals were sampled at 
4 kHz and digitized with an Axon analog/digital converter 
(Digidata 1440A). Data acquisition and analysis were 
performed using Clampfit software (version 10.3, Axon 
Instruments, Molecular Devices). For current-clamp re-
cordings, action potentials were evoked by electrical stim-
ulation with 1-ms, 2-nA current pulses at a frequency of 
1 Hz. The bath solution contained (in mmol/l): 126 NaCl, 
5.4 KCl, 1.8 CaCl2, 1.0 MgCl2, 20 HEPES, and 11 glucose 
(pH = 7.4 with NaOH). The pipette solution contained (in 
mmol/l): 90 K-aspartate, 30 KCl, 10 NaCl, 5.5. glucose, 1.0 
MgCl2, 10 EGTA, 4.0 Na-GTP, and 10 HEPES (pH = 7.2 
with KOH). Using the JPCalc application in the Clampex 
software (Molecular Devices), the liquid junction potential 
was estimated to be 13.4 mV at 37°C. Resting membrane 
potential was calculated by correcting for the liquid junc-
tion potential. The series resistance was <10  MΩ for all 
measurements included in the study and it was not com-
pensated. Dendrotoxin-K (10  nM; Sigma-Aldrich) was 
used to selectively block Kv1.1 channels, as done previ-
ously (Si et al., 2019). All chemicals used to make the bath 
and pipette solutions for recordings were obtained from 
Sigma-Aldrich.
2.6 | Histology
Whole hearts from age-matched 4- to 6-month-old mice 
(n = 5 per genotype; for WT: 5 females; for KO: 3 females, 
2 males) were excised following euthanasia by isoflurane 
overdose and then rinsed briefly in phosphate-buffered sa-
line (PBS), fixed in 10% neutral buffered formalin for 24 h, 
and transferred to 50% ethanol. Hearts were then embedded 
in paraffin, serial sectioned (5 μm) in the longitudinal (long 
axial) plane, mounted onto slides, and stained with Masson's 
trichrome. Microscopic cardiac pathology was determined 
by a board-certified and licensed expert pathologist (Dr. J. 
Traylor) who was blinded to genotype.
2.7 | Quantitative PCR analyses
Following euthanasia by cervical dislocation, a portion of 
the left ventricle of age- and sex-matched 6- to 8-week-old 
WT and KO mice (for WT: n = 13, including 7 males, 6 
females; for KO: n  =  10, including 5 males, 5 females) 
was quickly harvested and homogenized in ice-cold TRI 
reagent (Zymo Research, Irvine, CA). The tissue was 
carefully selected from the outer wall of the left ventri-
cle equidistant from the base and apex and approximately 
1  mm3 in volume. Total RNA was extracted using the 
PureLink RNA Mini Kit (Thermo Fisher, Waltham, MA). 
Genomic DNA was eliminated using the DNA-free DNA 
Removal Kit (Thermo Fisher). The quantity of total RNA 
was measured using a NanoDrop 1000 spectrophotometer 
(Thermo Fisher) and quality was confirmed using an RNA 
ScreenTape assay on a 2200 TapeStation system (Agilent, 
Santa Clara, CA). The resulting RNA integrity number was 
used to estimate total RNA integrity and only samples with 
scores >8.0 were used for experiments. The RNA sam-
ples (375 ng) were converted to first-strand cDNA using 
the iScript Advanced cDNA Kit for reverse transcriptase 
(RT)-quantitative PCR (qPCR) with oligo(dT) primers 
(Bio-Rad, Hercules, CA). qPCR of first-strand cDNA was 
performed with TaqMan gene expression assays (Thermo 
Fisher) that were designed and preoptimized by Thermo 
Fisher for the detection of Kcna4 (Mm00445241_s1), 
Kcna5 (Mm00524346_s1), Kcnb1 (Mm00492791_ m1), 
Kcnd2 (Mm01161732_m1), Kcnh2 (Mm00465377_mH), 
Kcnj2 (Mm00434616_m1), Kcnj3 (Mm00434618_m1), 
Kcnq1 (Mm00434640_ m1), Scn5a (Mm01342518_m1), 
and Cacna1c (Mm01188822_m1). qPCR experiments were 
performed using a 1:15 cDNA dilution, which was deter-
mined to be the optimal concentration by analyzing qPCR 
amplification across a five-point cDNA dilution series to 
generate a standard curve. Individual PCR reactions were 
performed in triplicate using cDNA and TaqMan Gene 
Expression Master Mix (Thermo Fisher) on a CFX96 Fast 
Real-Time PCR System (Bio-Rad). No template and no re-
verse transcriptase (–RT) reactions were included as nega-
tive controls to verify the absence of contamination leading 
to unwanted PCR amplification and detection. Reactions 
were normalized to the amplification threshold cycle (CT) 
of the housekeeping gene hypoxanthine phosphoribosyl-
transferase 1 (Hprt1; Mm03024075_m1). Relative mRNA 
expression was calculated as normalized values by use of 
the 2−ΔΔCT formula.
2.8 | Human protein measurements
Samples of right atrial (n = 6) and left ventricular (n = 3) tis-
sue from healthy control hearts were obtained from six male 
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donors between the ages of 44–59 years old. Hearts were ob-
tained from general organ donors whose undiseased hearts 
were explanted to obtain pulmonary and aortic valves for 
transplant surgery. Before cardiac explantation, organ donors 
did not receive medication other than dobutamine and plasma 
expanders. The cardioplegic solution used was Custodiol. All 
samples were frozen in liquid nitrogen and stored at −80°C. 
Sample collection and the experimental protocols were ap-
proved by the Scientific Board at the Hungarian Ministry 
of Health (ETT-TUKEB: 4991-0/2010-1018EKU) and per-
formed in accordance with the Declaration of Helsinki. Each 
patient gave written informed consent. Protein levels of 
KCNA1 (1:1000; Abcam, Cambridge, MA) were quantified 
by Western blotting and normalized to GAPDH (1:200,000; 
HyTest, Turku, Finland). Peroxidase-conjugated goat anti-
rabbit (1:5,000; Sigma-Aldrich, St. Louis, MO) and goat 
anti-mouse (1:50,000; Sigma-Aldrich) were used as second-
ary antibodies and visualized by chemifluorescencea (GE 
Healthcare, Chalfont St. Giles, UK). AIDA Image Analyzer 
Software (raytest, Straubenhardt, Germany) was used for 
analysis.
2.9 | Statistical analysis
All data are expressed as means  ±  standard deviation. For 
whole-cell patch-clamp electrophysiology data, the sample 
sizes (n) indicate the numbers of cells recorded and mice (i.e., 
total number of cells recorded/total number of mice used). 
Statistical analyses were performed using Prism for Windows 
(version 9; GraphPad Software, La Jolla, CA) and OriginPro 
(version 7.5, OriginLab, Northampton, MA). The D’Agostino-
Pearson test was used to test the normality of all electrophysi-
ology and echocardiography data and the distributions were 
found to be normal in all cases except for the APD50 values 
with DTX-K in WT mice and the echocardiographic measure-
ments of LVPWd in WT mice and LVAWd in KO mice. For 
comparisons involving two groups, either paired or unpaired 
two-tailed Student's t-tests were employed as appropriate. The 
action potential duration data were also analyzed using nested 
(i.e., hierarchical) t-tests and no significant differences were 
identified between animals of the same genotype.
3 |  RESULTS
3.1 | Kv1.1 deficiency alters ventricular 
repolarization and arrhythmia susceptibility
To determine whether Kv1.1 deficiency leads to altered 
ventricular arrhythmia (VA) susceptibility, intracardiac pro-
grammed electrical stimulation (PES) was performed on 
adult WT (n = 29) and Kcna1-null (KO) animals (n = 20), 
and ventricular responses were monitored and recorded using 
surface ECG and ventricular electrograms (Figure 1A-C). In 
response to PES, the incidence of inducible VA was similar 
between genotypes: 45% of WT animals were VA-positive 
at baseline versus 55% of KO animals (p  =  0.57, Fisher's 
exact test; Figure 1B). Following the administration of the 
β-adrenergic agonist, isoproterenol, which usually enhances 
susceptibility to VA (Meester et al., 1997), WT animals ex-
hibited a significantly higher incidence of pacing-induced 
VA (76%) compared to KO animals (40%; p = 0.017, Fisher's 
exact test; Figure 1C). These experiments provide evidence 
that the genetic deletion of Kv1.1 subunits decreases ven-
tricular arrhythmia susceptibility under conditions of sym-
pathetic challenge. Whether changes in VA incidence were 
associated with changes in the QT interval could not be as-
certained since the T wave was not reliably identifiable in the 
surface ECG recordings.
3.2 | Kv1.1 deficiency impairs ventricular 
contractility and efficiency
Echocardiographic measurements revealed significantly 
decreased ventricular function in KO hearts compared to 
WT hearts (Figure 1D). Specifically, the left ventricles 
(LVs) of KO mice exhibited significantly decreased stroke 
volume (−25%; p = 0.033, unpaired t-test), ejection frac-
tion (−17%; p  =  0.006, unpaired t-test), cardiac output 
(−26%; p = 0.001, unpaired t-test), and fractional shorten-
ing (−32%; p = 0.005, unpaired t-test), indicating impaired 
cardiac contractility and efficiency. However, measures 
of LV cavity dimensions and wall thickness in KO hearts 
were similar to WT, suggesting that the functional deficits 
in KO hearts were not associated with structural remod-
eling (Table 1).
3.3 | Kv1.1 deficiency prolongs ventricular 
action potentials
To determine the functional effects of Kv1.1 deficiency on 
the ventricles at the cellular level, whole-cell patch-clamp 
recordings of action potentials were obtained from iso-
lated WT and KO ventricular cardiomyocytes. In current-
clamp recordings, KO cells (n = 9) exhibited significantly 
prolonged action potential durations (+51%) compared to 
WT cells (n  =  12) when measured at 90% repolarization 
(APD90), which corresponds to the late phase of the ac-
tion potential (p  =  0.0039, unpaired t-test; Figure 2A,B). 
However, no significant differences were observed between 
genotypes for the APDs of the early (APD30; p = 0.50, un-
paired t-test) and middle phases (APD50; p = 0.39, unpaired 
t-test). Blockade of Kv1.1 channels using the Kv1.1-specific 
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inhibitor dendrotoxin-K (DTX-K; 10 nM) caused 33% pro-
longation of APD90 in WT cells (n = 8; p = 0.037, paired 
t-test; Figure 2C,D), but APD30 (p = 0.30, paired t-test) and 
APD50 (p  =  0.54, paired t-test), were not significantly af-
fected, mimicking the above observations in KO cells and 
demonstrating that both genetic and pharmacological inhi-
bition of Kv1.1 subunits impairs ventricular repolarization. 
Importantly, previous recordings from mouse cardiomyo-
cytes showed that DTX-K has no effect on APD in KO ani-
mals, as expected since DTX-K is specific for Kv channels 
containing Kv1.1 subunits (Si et al., 2019). Baseline resting 
membrane potential was not significantly different between 
WT (−97 ± 10 mV) and KO (−95 ± 6 mV) ventricular car-
diomyocytes (p = 0.54, unpaired t-test).
F I G U R E  1  Alterations of ventricular electrophysiology and function in Kcna1⎯/⎯ mice. (A) Representative surface ECG (lead I) and ventricular 
electrogram traces after pacing stimulation exhibiting no arrhythmia (top two traces) versus arrhythmia (bottom two traces) responses. (B-C) 
Incidence of pacing-induced ventricular arrhythmia (VA) (B) at baseline and (C) following isoproterenol (ISO) administration (4 mg/kg, i.p.) in 
WT (n = 29) and KO mice (n = 20). (D) Examples of M-mode echocardiography images from WT and KO mice showing increased left ventricular 
internal diameter during systole (LVIDs; dotted white arrow) in KO animals that leads to decreased ejection fraction and fractional shortening. The 
following parameters are also indicated: left ventricular internal diameter during diastole (LVIDd; solid white arrow); left ventricular anterior and 
poster wall thickness during systole [(LVAWs; dotted orange arrow) and (LVPWs; dotted yellow arrow), respectively]; and left ventricular anterior 
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3.4 | Kv1.1 deficiency does not cause 
structural or ion channel remodeling 
in ventricles
Since myocardial scarring, or fibrosis, is known to be asso-
ciated with alterations in overall cardiac function (Morita 
et al., 2014), the hearts of KO mice were inspected for 
microscopic structural lesions, such as excessive collagen 
deposition and cell death (Figure 2B). Masson's trichrome 
staining of WT and KO ventricular tissue (n = 5 per geno-
type) revealed the presence of minor focal subendocardial 
fibrosis that was restricted to the papillary muscles, but this 
finding was present in both genotypes in 40% of hearts. 
Notably, KO hearts revealed no evidence of increased my-
ocardial interstitial fibrosis in the ventricular wall, where it 
could have a detrimental impact on cardiac function. The 
absence of both microscopic and macroscopic (Figure 1D; 
Table 1) structural abnormalities in KO ventricles suggests 
that the alterations in heart function due to Kv1.1 defi-
ciency are likely electrophysiological rather than structural 
in nature.
To test whether Kcna1 deletion leads to changes in the ex-
pression of other ventricular ion channels which could under-
lie the electrophysiological phenotypes observed, quantitative 
RT-PCR (qPCR) was performed to measure mRNA transcript 
levels of other prominent ion channels that contribute to ac-
tion potential morphology and repolarization (Figure 3B). The 
following genes (with their associated protein and current) 
were measured: Kcna4 (Kv1.4; Ito,s); Kcna5 (Kv1.5; IK,slow1); 
Kcnb1 (Kv2.1; IK,slow2); Kcnd2 (Kv4.2; Ito,f); Kcnh2 (Kv11.1/
mERG; IKr); Kcnj2 (Kir2.1; IK1); Kcnj3 (Kir3.1; IK,ACh); Kcnq1 
(Kv7.1; Iss); Scn5a (Nav1.5; INa); and Cacna1c (Cav1.2; ICa,L). 
qPCR comparisons revealed no significant remodeling of any 
single ventricular ion channel gene due to Kcna1 deletion, 
suggesting that the absence of Kv1.1 channels, and not expres-
sion remodeling of other channels, may be the primary de-
fect underlying the observed electrophysiological alterations 
in the ventricles of KO hearts. One inherent limitation of our 
measurements was the presence of non-myocyte cell types in 
our ventricular tissue samples which could contribute to gene 
expression. In addition, Kv1.1 deficiency could also influence 
cardiac physiology by inducing changes in other channels at 
the levels of protein expression, post-translational regulation, 
or subcellular regulation.
T A B L E  1  Echocardiographic measurements in WT and KO mice
WT 
(n = 11) KO (n = 9) p-value
HR (bpm) 427 ± 56 385 ± 54 0.108
SV (mm3) 35 ± 8 26 ± 9 0.033*
EF (%) 74 ± 11 61 ± 7 0.006**
FS (%) 44 ± 10 32 ± 5 0.005**
CO (ml/min) 15 ± 2 10 ± 3 0.001**
LV mass (mg) 111 ± 23 122 ± 37 0.440
LV mass corr (mg) 89 ± 19 98 ± 29 0.440
LVAWs (mm) 1.6 ± 0.4 1.4 ± 0.5 0.380
LVAWd (mm) 1.2 ± 0.5 1.1 ± 0.4 0.616
LVPWs (mm) 1.3 ± 0.3 1.1 ± 0.4 0.733
LVPWd (mm) 0.9 ± 0.3 1.0 ± 0.3 0.545
LVIDs (mm) 3.4 ± 0.8 3.4 ± 0.5 0.381
LVIDd (mm) 2.0 ± 0.9 2.3 ± 0.5 0.358
Data are expressed as mean ± standard deviation. 2-tailed unpaired Student’s 
t-test was used to compare intragroup differences.
Abbreviations: HR, heart rate; SV, stroke volume; EF, ejection fraction; FS, 
fractional shortening; CO, cardiac output; LV Mass, left ventricular mass; LV 
Mass Corr, corrected left ventricular mass; LVAWs, left ventricular anterior 
wall thickness during systole; LVAWd, left ventricular anterior wall thickness 
during diastole; LVIDs, left ventricular internal diameter during systole; LVIDd, 
left ventricular internal diameter during diastole; LVPWs, left ventricular 
posterior wall thickness during systole; LVPWd, left ventricular posterior wall 
thickness during diastole; bpm, beats per minute.
*p < 0.05. 
**p < 0.01. 
F I G U R E  2  Effects of Kv1.1 deletion and inhibition on 
action potential morphology of ventricular cardiomyocytes. (A) 
Representative whole-cell patch-clamp action potential recordings 
from wild-type (WT) and Kcna1⎯/⎯ (KO) myocytes. (B) Average 
action potential duration (APD) in WT and KO cells at 30, 50, and 
90% repolarization (APD30, APD50, and APD90, respectively) (C) 
Representative ventricular action potential recordings in a WT cell 
at baseline (black line) overlaid with the resulting action potential 
after the application of 10 nM DTX-K (red line). (D) Average action 
potential duration (APD) in WT cells at APD30, APD50, and APD90 
before (control) and after (DTX-K) application of 10 nM DTX-K. 
Sample numbers (n) indicate numbers of myocytes and mice. *, 
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3.5 | Kv1.1 protein is present in 
human ventricles
To determine if ventricular Kv1.1 subunits may have poten-
tial functional significance in patients, human ventricle sam-
ples (n = 3) were examined for the presence of Kv1.1 protein 
and the levels compared to atrial samples (n  =  6). Using 
immunoblotting, Kv1.1 was detected in human ventricles for 
the first time. Interestingly, protein quantification showed 
that Kv1.1 was not only present but abundant in human ven-
tricles at levels similar to atria (p = 0.064, 2-tailed unpaired t-
test), which is in contrast to mice which exhibit higher levels 
in atria (Figure 4) (Glasscock et al., 2015). However, because 
these experiments were performed in tissue samples and not 
F I G U R E  3  Absence of obvious structural and expression remodeling in Kcna1⎯/⎯ mice. (A) Representative images of ventricular sections from 
WT (n = 5) and KO (n = 5) animals stained with Masson's trichrome to visualize fibrosis. Positive fibrosis staining appears light blue in color. The 
boxed regions in the upper panels are shown at higher magnification in the lower panels. (B) Relative mRNA expression profile of ion channel 
subunits important for action potential generation, as measured in left ventricular tissue from WT (n = 13) and KO (n = 10) animals. Expression 
levels were normalized to Hprt1 as a reference gene.
a
b
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isolated myocytes, a contribution by other non-myocyte cell 
types cannot be excluded.
4 |  DISCUSSION
This study reveals new functional roles for the recently dis-
covered cardiac ion channel Kv1.1 in regulating ventricular 
arrhythmia susceptibility, contractility, and repolarization. 
By several electrophysiological approaches, this work dem-
onstrates that the genetic ablation of Kcna1 impacts the 
function of the ventricles at the organ and cellular levels. 
Although KO mice exhibited normal susceptibility to induc-
ible VA at baseline, they showed resistance to VA relative 
to WT mice when subjected to sympathetic challenge with 
isoproterenol. Echocardiography revealed additional evi-
dence of ventricular dysfunction, including deficits in ejec-
tion fraction and fractional shortening. At the cellular level, 
APD prolongation was evident in recordings of isolated ven-
tricular cardiomyocytes from KO mice. Notably, no evidence 
of structural or ion channel gene expression remodeling was 
observed in ventricles from KO mice, suggesting that the 
functional consequences of Kv1.1 deficiency are electrical 
in origin. Finally, protein analysis of human cardiac tissue 
revealed that Kv1.1 is not only present in the ventricles but 
that it is also expressed at levels comparable to atrial Kv1.1, 
further supporting the importance of the future exploration 
of the role of Kv1.1 in normal and pathological ventricular 
electrophysiology.
Because Kcna1 is dually expressed in both heart and 
brain, a single gene mutation can theoretically cause altered 
excitability of both organ systems and thereby result in a 
“double hit” on cardiac function that could potentially in-
crease the risk of sudden death, especially when seizures 
occur (Glasscock, 2014; Goldman, 2015; Goldman et al., 
2016). Previous studies have shown that Kv1.1 deficiency 
can promote cardiac abnormalities by brain-mediated 
mechanisms via autonomic dysregulation that can lead to 
SUDEP (Glasscock et al., 2010, 2012; Mishra et al., 2017; 
Moore et al., 2014). In addition, neuron-specific deletion 
of Kcna1 in mice causes a milder SUDEP phenotype than 
global gene deletion, suggesting that Kv1.1 deficiency 
in the heart combines with Kv1.1 deficiency in the brain 
to augment risk (Trosclair et al., 2020). In this study, the 
absence of Kv1.1 in the heart did not render it more sus-
ceptible to sympathetic-mediated arrhythmogenic ventric-
ular dysfunction since isoproterenol administration did not 
augment VA susceptibility, suggesting that Kv1.1 KO mice 
may be resistant to catecholaminergic effects of seizures on 
the heart. However, as demonstrated previously in canine 
cardiac recordings, the administration of catecholamines 
does not exactly mimic the pro-fibrillatory effects of the in-
trinsic activation of the sympathetic nervous system by di-
rect or reflex stimulation (Han & Moe, 1964). Furthermore, 
the mode of sympathetic stimulation, whether a sympa-
thetic surge (such as a seizure) or high sympathetic tone 
(such as continuous β-adrenergic stimulation), can have 
differential effects on arrhythmia susceptibility depend-
ing on the underlying genetics and pathophysiology (Liu 
et al., 2012). Thus, it remains to be determined whether 
the resistance of Kv1.1 KO mice to inducible VA in the 
presence of isoproterenol is indicative of an intrinsic cardi-
oprotective effect of Kv1.1-deficiency against spontaneous 
seizure-related catecholamine surges. In addition, previous 
studies suggest that parasympathetic mechanisms may be 
of greater importance for SUDEP risk in this model since 
global Kv1.1 KO mice exhibit seizure-associated brady-
cardia and asystole immediately preceding death, as well 
as prolonged survival with unilateral vagotomy (Glasscock 
et al., 2010; Moore et al., 2014). One possibility is that 
Kv1.1 KO mice exhibit underlying alterations in β-adren-
ergic receptor expression or circulating catecholamine lev-
els which could influence their isoproterenol response but 
this remains to be determined. Additional studies will be 
required to clarify the complex relationship between Kv1.1 
deficiency in the heart and susceptibility to seizure-related 
cardiac arrhythmias that could contribute to sudden death.
This study provides the first characterization of the role 
of Kv1.1 in the ventricles, allowing comparisons to be made 
between Kv1.1 expression and function in ventricular ver-
sus atrial tissues where Kv1.1 has already been examined. 
Although Kv1.1 is present at both the transcript and protein 
level in atrial and ventricular cardiomyocytes, quantitative 
PCR and immunocytochemistry studies indicate a higher 
F I G U R E  4  Kv1.1 protein is present in both human atria and 
ventricles. Representative western blot of Kv1.1 protein in two human 
right atrial (RA) and left ventricular (LV) samples with corresponding 
densitometric quantification (mean ± standard deviation) of protein 
levels normalized to GAPDH (loading control) and expressed relative 
to atrial Kv1.1 expression
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abundance of Kv1.1 (up to ~10-fold) in murine atrial cells 
compared to ventricular cells, suggesting possible differ-
ences in the functional importance of Kv1.1 in the two 
regions (Glasscock et al., 2015). While neither atrial nor 
ventricular tissues from Kv1.1 KO mice exhibit abnormal 
levels of interstitial fibrosis, the tissues show markedly 
different electrophysiological properties (Glasscock et al., 
2015; Si et al., 2019). For example, Kv1.1 deficiency is 
arrhythmogenic in atria, but has no effect on arrhythmia 
susceptibility in the ventricles except under conditions of 
β-adrenergic stimulation when it is apparently arrhyth-
mia-resistant (Glasscock et al., 2015). Additionally, Kv1.1 
deficiency leads to ion channel transcript remodeling in 
the atria, but not in the ventricles (Si et al., 2019). At the 
cellular level, both atrial and ventricular Kv1.1-deficient 
cardiomyocytes have prolonged action potentials, but their 
degree of prolongation is chamber-specific. Atrial KO cells 
exhibit an average APD90 prolongation of ~100% compared 
to WT, whereas APD90 in ventricular KO cells was only 
~50% longer (Si et al., 2019). Finally, in contrast to Kv1.1 
expression patterns in mice, patient samples in the present 
study show similar levels of Kv1.1 protein in the ventricles 
and atria, suggesting the importance of Kv1.1 in human 
heart in both chambers. Taken together, these findings em-
phasize the need to further investigate regional differences 
in the role of Kv1.1 in the heart.
A potential limitation of this study for inferring cardiac 
mechanisms of SUDEP is that the ages of the animals used 
for in vivo measurements were beyond the time window 
when premature death most frequently occurs in this model. 
Our previous studies show that most Kv1.1 KO mice ex-
hibit premature death between the ages of 2 to 7 weeks old 
(Trosclair et al., 2020). However, the mice used for the in 
vivo and histological experiments in this research ranged in 
age from approximately 17 to 34 weeks. Older mice were re-
quired in this study to address technical considerations, such 
as needing larger, older animals for venous catheter insertion 
in intracardiac pacing experiments and to increase the like-
lihood of detecting echocardiographic deficits, which tend 
to predominate in older animals. Another limitation of our 
echocardiographic analyses was that measurements were 
only performed in female mice of both genotypes due to a 
lack of availability of age-matched male KO mice. Although 
the ages of the mice in our study tended to be older than the 
age window of maximal SUDEP risk in Kv1.1 KO mice, 
our findings still demonstrate the general cardiac effects of 
chronic Kv1.1 deficiency and the important requirement of 
Kv1.1 channels for normal heart function.
In summary, this work discloses a functional role for 
Kv1.1 subunits in the ventricles for the first time by demon-
strating that Kcna1 gene deletion in mice impairs both con-
tractility and cardiac repolarization and alters arrhythmia 
susceptibility. Furthermore, the absence of significant 
underlying structural or channel remodeling implies these 
abnormalities are electrical in origin. The detectable levels 
of Kv1.1 in human ventricles suggest KCNA1 could con-
tribute to human ventricular pathology. However, given the 
lack of reported cardiac symptoms in patients with EA1 
or epilepsy, the cardiac repolarization reserve may be ca-
pable of compensating for Kv1.1-associated repolarization 
abnormalities. Alternatively, since traditionally Kv1.1 sub-
units have not been considered to have a role in the heart, 
the lack of identified Kv1.1-associated cardiac deficits in 
patients could be due to ascertainment bias from patients 
not being clinically examined for cardiac dysfunction. As 
our understanding of the pathological mechanisms of inher-
ited cardiac arrhythmias and SUDEP continues to evolve, it 
is important to consider the previously overlooked role of 
Kv1.1 in the ventricles and its potential impact on cardiac 
electrophysiology in health and disease.
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